webLoaded = "false" Loadclientside=No

3M™ PEAK™ Clinical Outcomes Program: Bloodstream Infections


webLoaded = "false" Loadclientside=No
Male patient in a hospital bed featuring 3M™ Tegaderm™ CHG Dressing 1657
Path Toward Zero

Partnering with you on your path toward zero bloodstream infections

webLoaded = "false"
  • Every IV site presents the potential for infection, dislodgment, skin damage and other complications. These complications can potentially cause patient discomfort and pain, extended hospital stays, additional therapy, and surgical intervention—even increased patient mortality.


webLoaded = "false"
  • $2.3 billion icon

    $2.3 Billion

    Nationwide, the annual cost to treat CLABSI exceeds $2.3 billion

  • 1 in 4 icon

    1 in 4

    1 in 4 who contract a CLABSI will die

  • 10x increase icon

    10x Increase

    More than 2 central line dressing disruptions can result in a 10x increase in infection risk

  • Icon of a Hospital

    12-24 more days in a hospital

    Evidence has demonstrated an increase in hospital resources, and associated costs, required to treat morbidities due to CRBSIs₄₋₇


webLoaded = "false"

The PEAK™ Program difference

  • Icon of central and peripheral lines

    All lines, all the time

    Every IV site presents the potential for IV site complications. That is why we provide support and education for both central and peripheral lines, as well as for every brand of catheter.

  • Icon of IV care practices

    IV care expertise

    Most bloodstream infections (BSIs) happen after insertion.⁸ 3M understands that IV care cannot be an afterthought to insertion; it must be an area of passionate focus. This is why we have been collaborating with clinicians for over 35 years to find new ways to continue improving IV care practices.


webLoaded = "false"

PEAK™ Progam Resources

  • Image of PEAK Brochure

    Learn how you can partner with 3M on your path toward zero IV complications.

  • Icon of PEAK program

    See how the PEAK program can help you successfully implement and sustain your clinical outcomes.

  • Image of PEAK spelled out

    Learn more about the PEAK Program's proven process for successful change implementation: Prepare, Educate, Assess and Keep it Up.

  • Image of a graph chart

    Discover the five key attributes that make the PEAK Program unique.


webLoaded = "false"

Get Started

We provide a robust portfolio of tools and processes, along with the support of 3M Clinical Specialists and Sales Representatives to work hand-in-hand with you each step of the way.

  • PEAK Program Resource Center

    PEAK Program Resource Center

    We want everyone who welcomes 3M IV solutions into their facility to be successful. We will work directly with you to customize and refine every step of your PEAK Program journey – from training plans to auditing parameters.

    Existing Users: Log In

  • 3M™ PEAK™ Assessment Tool

    3M™ PEAK™ Assessment Tool

    The PEAK Assessment Tool empowers you to drive compliance by streamlining the auditing process and receiving customized, real-time feedback. We understand every journey toward zero is unique, which is why the PEAK Assessment Tool allows you to choose audit scope, audit frequency, data collection method, and how to define success.

    For more information, please contact your 3M representative.

  • Implement PEAK

    Connect with a 3M Specialist

    Are you interested in learning more about how 3M can help you on your path toward zero bloodstream infections at your facility?


Close  
webLoaded = "false"
  • 1. Provonost P, Needham D, Berenholtz S, et al. An intervention to decrease cather-related bloodstream infections in the ICU. N Engl J Med. 2006; 355(26); 2725.

    2. Centers for Disease Control and Prevention. Division of Healthcare Quality Promotion. Making health care safer: reducing bloodstream infections. 2011. https://www.cdc.gov/vitalsigns/pdf/2011-03-vitalsigns.pdf (PDF, 2.75 MB).

    3. Timsit, J et al (2012). Dressing disruption is a major risk factor for catheter-related infections. Critical Care Medicine. Vol 40(6) 1707-1714.

    4. O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II. Guidelines for the prevention of intravascular catheter–related infections. Clinical infectious diseases. 2002 Dec 1;35(11):1281-307.

    5. Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, Decruyenaere J, Vogelaers D, Colardyn F, Vandewoude KH. Clinicaland economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clinical Infectious Diseases. 2005 Dec 1;41(11):1591-8.

    6. Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia: a cohort and case-control study in critically illpatients. Am J Respir Crit Care Med 2001; 163:1584–90.

    7. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001; 136: 229–234.

    8. “Guide to Preventing Central Line-Associated Bloodstream Infections.” Association for Professionals in Infection Control and Epidemiology. 2015.
    https://apic.org/Resource_/TinyMceFileManager/2015/APIC_CLABSI_WEB.pdf (PDF, 2.19 MB)


Follow Us
Change Location
United States - English